Lymphoblastic Leukemia, Acute, Childhood Completed Phase 1 Trials for Panobinostat (DB06603)

IndicationStatusPhase
DBCOND0044925 (Lymphoblastic Leukemia, Acute, Childhood)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01321346A Study Of Panobinostat In Children With Refractory Hematologic MalignanciesTreatment